Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revolution MD is a medical technology and digital health company focused on addressing the opioid epidemic through safe, controlled drug delivery. The company is developing a patented Smart Inhaler platform that integrates biometric authentication, location sensors, and advanced physiological monitoring to prevent opioid misuse, diversion, and overdose. Controlled by a secure, real-time communications network, the system allows healthcare providers to remotely monitor patient compliance, activate or deactivate devices, and safely taper medication. Additionally, Revolution MD is pioneering AI-driven predictive diagnostics to assess patient risk for opioid addiction before exposure. By combining precise inhalation-based dosing with a digital oversight infrastructure, the company aims to provide patients with reliable pain relief while ensuring unprecedented clinical accountability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revolution MD.